Stereotactic Body Radiation Therapy for Intermediate-risk Prostate Cancer With VMAT and Real-time Electromagnetic Tracking: A Phase II Study
Conclusion:
Ultrahypofractionated radiotherapy, delivered with flattening filter free-volumetric modulated arc therapy and gated by electromagnetic transponders, is a valid option for intermediate-risk prostate cancer.
Source: American Journal of Clinical Oncology - Category: Cancer & Oncology Tags: Original Articles: Genitourinary Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | CT Scan | Gastroenterology | Pathology | PET Scan | Prostate Cancer | Radiation Therapy | Study | Toxicology | Urology & Nephrology